Healthtech News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests
NewsDealsSocialBlogsVideosPodcasts
HealthtechNewsASE Promoting 3D Echo as a Better Way to Treat Congenital Heart Disease
ASE Promoting 3D Echo as a Better Way to Treat Congenital Heart Disease
HealthTechHealthcare

ASE Promoting 3D Echo as a Better Way to Treat Congenital Heart Disease

•February 23, 2026
0
Cardiovascular Business
Cardiovascular Business•Feb 23, 2026

Why It Matters

Enhanced 3D imaging boosts diagnostic precision and procedural efficiency, directly improving outcomes for congenital heart patients and accelerating technology adoption across cardiac specialties.

Key Takeaways

  • •ASE standardizes 3D echo imaging and terminology
  • •3D echo improves anatomical visualization over 2D
  • •New pediatric 3D TEE probe expands procedural guidance
  • •Training events scheduled for June meeting and November virtual course
  • •Faster learning expected for all imagers, not just specialists

Pulse Analysis

Congenital heart disease remains one of the most complex areas of cardiovascular care, demanding precise imaging to guide both surgical repair and catheter‑based interventions. Traditional two‑dimensional echocardiography often falls short in depicting intricate spatial relationships, leading to longer procedure times and higher risk of misinterpretation. By promoting three‑dimensional echo, the American Society of Echocardiography is addressing these gaps, offering clinicians a volumetric view that mirrors real‑world anatomy and supports more confident decision‑making during pre‑operative planning and intra‑operative guidance.

The technical leap provided by 3D echo is amplified by recent advances such as the pediatric‑specific three‑dimensional transesophageal echocardiography (TEE) probe. This device delivers high‑resolution, real‑time images directly within the operating room or cath lab, allowing surgeons and interventionalists to assess valve morphology, septal defects, and vascular connections with unprecedented clarity. Compared with conventional 2D imaging, the 3D approach reduces measurement variability, shortens procedural duration, and can lower radiation exposure by minimizing the need for supplemental fluoroscopy. Early adopters report improved surgical outcomes and smoother postoperative recovery, underscoring the clinical value of this technology.

ASE’s commitment to education ensures that the benefits of 3D echo extend beyond specialist centers. By integrating standardized image presentation and unified terminology into its annual meeting and the November virtual experience, the society accelerates skill transfer to a broader cohort of imagers. Rapid learning curves mean that community hospitals and emerging cardiac programs can adopt the technology without extensive downtime. As more institutions incorporate 3D echo into routine practice, the market for advanced ultrasound platforms is poised for growth, and the overall standard of care for congenital heart disease patients is set to rise dramatically.

ASE promoting 3D echo as a better way to treat congenital heart disease

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...